A Pilot Study to Evaluate the Contribution of the Saphenous Nerve in Ankle Pain of Patients With Degenerative Joint Disease of the Ankle

Terminated

• Conditions: Degenerative Joint Disease of the Ankle

• Registration Number: NCT01716650
• Lead Sponsor: Mayo Clinic

Brief Summary

To assess the pain scores before and after saphenous nerve block placement in patients with degenerative joint disease of the ankle

Detailed Description

Not available

Study Timeline

• Study Start: 2012-10
• Study First Submitted: 2012-10-24
• Study First Submitted QC: 2012-10-25
• Study First Posted: 2012-10-30
• Primary Completion: 2016-09
• Study Completion: 2016-09
• Status Verified: 2017-12
• Last Update Submitted: 2019-04-04
• Last Update Posted: 2019-04-08

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 4

Inclusion Criteria

• Patients evaluated with osteoarthritis who are surgical candidates for ankle fusion or total ankle replacement.
• Registered patients at Mayo Clinic in Florida with scheduled visit to see Dr.Whalen

Read More

Exclusion Criteria

• Patients with lower extremity diabetic neuropathy
• History of prior trauma of ankle with residual nerve injury
• Current medication of pregabalin or gabalin
• Allergy to lidocaine.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Ankle pain	30 minutes	Patient's ankle pain will be assessed prior to and after the nerve block. The study will assess if pain score is lower after the saphenous nerve block

Trial Locations

Locations (1)

Mayo Clinic; 🇺🇸 Jacksonville, Florida, United States